Inpatient Medicine Associates (Imac) Pl is categorized under Health Services in Orlando, FL and active since 2008.
Inpatient Medicine Associates (Imac) Pl was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Arshad Rehman at the company’s single location by writing to 4108 North Mira Boulevard, Orlando, Florida FL 32817 or by phoning (321) 303-6457. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Inpatient Medicine Associates (Imac) Pl |
Contact Person: | Arshad Rehman |
Address: | 4108 North Mira Boulevard, Orlando, Florida 32817 |
Phone Number: | (321) 303-6457 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Inpatient Medicine Associates (Imac) Pl was started in 2008 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Arshad Rehman for inquiries that concern Inpatient Medicine Associates (Imac) Pl by calling the company number (321) 303-6457, as your correspondence is most welcome. Additionally, the physical location of the single location of Inpatient Medicine Associates (Imac) Pl can be found at the coordinates 28.600069,-81.27477 as well as the street address 4108 North Mira Boulevard in Orlando, Florida 32817.
For its online presence, you may visit Inpatient Medicine Associates (Imac) Pl’s website at and engage with its social media outlets through on Twitter and on Facebook.